Literature DB >> 23403313

Acute myeloid leukemia with translocation t(3;5): new molecular insights.

Florent Dumézy, Aline Renneville, Caroline Mayeur-Rousse, Olivier Nibourel, Elise Labis, Claude Preudhomme.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23403313      PMCID： PMC3660006          DOI： 10.3324/haematol.2012.082149

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  11 in total

1.  Elevated MLF1 expression correlates with malignant progression from myelodysplastic syndrome.

Authors:  N Matsumoto; N Yoneda-Kato; T Iguchi; Y Kishimoto; T Kyo; H Sawada; E Tatsumi; S Fukuhara
Journal:  Leukemia       Date:  2000-10       Impact factor: 11.528

2.  Prognostic significance of DNA methyltransferase 3A mutations in cytogenetically normal acute myeloid leukemia: a study by the Acute Leukemia French Association.

Authors:  A Renneville; N Boissel; O Nibourel; C Berthon; N Helevaut; C Gardin; J-M Cayuela; S Hayette; O Reman; N Contentin; D Bordessoule; C Pautas; S de Botton; T de Revel; C Terre; P Fenaux; X Thomas; S Castaigne; H Dombret; C Preudhomme
Journal:  Leukemia       Date:  2012-01-13       Impact factor: 11.528

3.  Loss of the NPM1 gene in myeloid disorders with chromosome 5 rearrangements.

Authors:  R Berger; M Busson; L Baranger; C Hélias; M Lessard; N Dastugue; F Speleman
Journal:  Leukemia       Date:  2006-02       Impact factor: 11.528

4.  Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials.

Authors:  David Grimwade; Robert K Hills; Anthony V Moorman; Helen Walker; Stephen Chatters; Anthony H Goldstone; Keith Wheatley; Christine J Harrison; Alan K Burnett
Journal:  Blood       Date:  2010-04-12       Impact factor: 22.113

5.  Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype.

Authors:  Brunangelo Falini; Cristina Mecucci; Enrico Tiacci; Myriam Alcalay; Roberto Rosati; Laura Pasqualucci; Roberta La Starza; Daniela Diverio; Emanuela Colombo; Antonella Santucci; Barbara Bigerna; Roberta Pacini; Alessandra Pucciarini; Arcangelo Liso; Marco Vignetti; Paola Fazi; Natalia Meani; Valentina Pettirossi; Giuseppe Saglio; Franco Mandelli; Francesco Lo-Coco; Pier-Giuseppe Pelicci; Massimo F Martelli
Journal:  N Engl J Med       Date:  2005-01-20       Impact factor: 91.245

6.  Mutations in nucleophosmin (NPM1) in acute myeloid leukemia (AML): association with other gene abnormalities and previously established gene expression signatures and their favorable prognostic significance.

Authors:  Roel G W Verhaak; Chantal S Goudswaard; Wim van Putten; Maarten A Bijl; Mathijs A Sanders; Wendy Hugens; André G Uitterlinden; Claudia A J Erpelinck; Ruud Delwel; Bob Löwenberg; Peter J M Valk
Journal:  Blood       Date:  2005-08-18       Impact factor: 22.113

Review 7.  The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes.

Authors:  James W Vardiman; Jüergen Thiele; Daniel A Arber; Richard D Brunning; Michael J Borowitz; Anna Porwit; Nancy Lee Harris; Michelle M Le Beau; Eva Hellström-Lindberg; Ayalew Tefferi; Clara D Bloomfield
Journal:  Blood       Date:  2009-04-08       Impact factor: 22.113

8.  The t(3;5)(q25.1;q34) of myelodysplastic syndrome and acute myeloid leukemia produces a novel fusion gene, NPM-MLF1.

Authors:  N Yoneda-Kato; A T Look; M N Kirstein; M B Valentine; S C Raimondi; K J Cohen; A J Carroll; S W Morris
Journal:  Oncogene       Date:  1996-01-18       Impact factor: 9.867

Review 9.  Clinicopathologic manifestations and breakpoints of the t(3;5) in patients with acute nonlymphocytic leukemia.

Authors:  S C Raimondi; I D Dubé; M B Valentine; J Mirro; H J Watt; R A Larson; M A Bitter; M M Le Beau; J D Rowley
Journal:  Leukemia       Date:  1989-01       Impact factor: 11.528

10.  NPM1 mutations and cytoplasmic nucleophosmin are mutually exclusive of recurrent genetic abnormalities: a comparative analysis of 2562 patients with acute myeloid leukemia.

Authors:  Brunangelo Falini; Cristina Mecucci; Giuseppe Saglio; Francesco Lo Coco; Daniela Diverio; Patrick Brown; Fabrizio Pane; Marco Mancini; Maria Paola Martelli; Stefano Pileri; Torsten Haferlach; Claudia Haferlach; Susanne Schnittger
Journal:  Haematologica       Date:  2008-02-11       Impact factor: 9.941
View more
  2 in total

Review 1.  Rare Cytogenetic Abnormalities and Alteration of microRNAs in Acute Myeloid Leukemia and Response to Therapy.

Authors:  Mohammad Shahjahani; Elahe Khodadi; Mohammad Seghatoleslami; Javad Mohammadi Asl; Neda Golchin; Zeynab Deris Zaieri; Najmaldin Saki
Journal:  Oncol Rev       Date:  2015-03-09

2.  Identification of novel diagnostic biomarkers for thyroid carcinoma.

Authors:  Xiliang Wang; Qing Zhang; Zhiming Cai; Yifan Dai; Lisha Mou
Journal:  Oncotarget       Date:  2017-12-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.